13 Horev St.

Haifa, 3434117

Israel

This project has received funding from the European Union’s Horizon 2020 Programme for research, technological development and demonstration under grant agreement No 644031.

Sniffphone Logo_M.png

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No H2020-SMEINST-865082

© 2019 by NANOVATION-GS LTD. All rights reserved.

NanoVation

Respiratory Monitoring Innovation

Detect respiratory changes before reaching critical stages

Overview

 
IMPROVING THE MANAGEMENT OF CHRONIC RESPIRATORY CONDITIONS

We provide a reliable solution for monitoring of chronic respiratory diseases, such as COPD and asthma. Our aim is to improve the outcomes of patient's respiratory deteriorations by enabling early identification and intervention at home.

250M COPD patients worldwide

150% increase by 2030

High economical burden

Repeating hospitalizations

3M

annual deaths

3rd leading cause of death

REDUCE UNNECESSARY HOSPITALIZATION AND ASSOCIATED COSTS

Continuous remote monitoring

Identify/predict deterioration

Enable early intervention

Reduce hospital readmission

Our patented technology can identify subtle changes in patient's respiratory condition, enabling healthcare professionals to take proactive measures and prevent patient’s exacerbations and unnecessary hospitalizations. The annual spending in US on COPD alone is 50B, of which 14B are for hospitalizations. Over 20% of COPD patients are readmitted within 30 days. Clinical tests have proven that providing continuous oversight after discharge can dramatically reduce readmissions and decrease healthcare costs.

5.5k

HOSPITALS

Pay for readmissions.

Monitor patients at
homes.

INSURERS

40

Pay for admissions and management.

Utilize Home HC
services.

HOME HC AGENCIES

13K

Patient management & home monitoring
services for
hospitals
& insurers.

20M

PATIENTS

Pay for readmissions.

Monitor patients at
homes.

STAKEHOLDERS IN USA

SenseGuard

TM

SENSEGUARD ENABLES CONTINUOUS REMOTE RESPIRATORY MONITORING

An innovative wireless wearable device that enables continuous and non-invasive monitoring of critical respiratory parameters derived from patients' tidal (normal) breathing, cancelling the need for forced expirations.

A COMPREHENSIVE SOLUTION FOR MONITORING RESPIRATION

Respiration Rate

Inspiration/Expiration

Respiratory Depth

Respiratory Variability

Apneas Frequency & Duration

Respiratory Waveform

KEY BENEFITS OF THE SENSEGUARD

Monitoring at homes and hospitals

Periodic or continuous evaluation of lung functions

Wearable and wireless, so the patient can be monitored anytime, anywhere

Non-invasive, effortless and easy to use

Zero movement artifacts

 
 
Contact Us